The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion. Hara T, Furukawa J, Okamura Y, Bando Y, et al. Int J Urol 2023;30:779-786.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hara T, Furukawa J, Okamura Y, Bando Y, et al. The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion. Int J Urol 2023;30:779-786.
PMID: 37317886